Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants. by Nicole Espy, Xue Han, Shannon Grant, Esther Kwara, Bharathi Lakshminarayanan, Michael Stirewalt, Kelly E Seaton, Georgia D Tomaras, Erin Goecker, Julie McElrath, Jessica Andriesen, Yunda Huang, Stephen R Walsh, John Hural

Connect to this object online.

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants by Nicole Espy, Xue Han, Shannon Grant, Esther Kwara, Bharathi Lakshminarayanan, Michael Stirewalt, Kelly E. Seaton, Georgia D. Tomaras, Erin Goecker, Julie McElrath, Jessica Andriesen, Yunda Huang, Stephen R. Walsh, John Hural

Connect to this object online.

Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV by Bryan T. Mayer, Lily Zhang, Allan C. deCamp, Chenchen Yu, Alicia Sato, Heather Angier, Kelly E. Seaton, Nicole Yates, Julie E. Ledgerwood, Kenneth Mayer, Marina Caskey, Michel Nussenzweig, Kathryn Stephenson, Boris Julg, Dan H. Barouch, Magdalena E. Sobieszczyk, Srilatha Edupuganti, Colleen F. Kelley, M. Juliana McElrath, Huub C. Gelderblom, Michael Pensiero, Adrian McDermott, Lucio Gama, Richard A. Koup, Peter B. Gilbert, Myron S. Cohen, Lawrence Corey, Ollivier Hyrien, Georgia D. Tomaras, Yunda Huang

Connect to this object online.